SCHEMBL24495458

SCHEMBL24495458

COc1ccc(Cl)cc1/C=N/O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.69
TSHR P16473 3/20 0.69
MAPT P10636 5/20 0.55
KMT2A Q03164 9/20 0.51
MEN1 O00255 6/20 0.50
HTT P42858 2/20 0.50
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
LMNA P02545 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C19 P33261 2/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
POLB P06746 1/20 0.50
ALPG P10696 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2447956 1.00 HPGD (0.69) HPGDTSHRMAPTKMT2AMEN1
SCHEMBL2447953 1.00 HPGD (0.69) HPGDTSHRMAPTKMT2AMEN1
SCHEMBL29687081 1.00 HPGD (0.69) HPGDTSHRMAPTKMT2AMEN1
SCHEMBL17041014 0.81 HPGD (1.00) HPGDTSHRMAPTKMT2AMEN1
SCHEMBL3739640 0.80 CYP1A1 (0.56) HPGDMAPTKMT2AMEN1HTT
SCHEMBL3739643 0.80 CYP1A1 (0.56) HPGDMAPTKMT2AMEN1HTT
SCHEMBL20125076 0.80 ACHE (0.50) HPGDTSHRMAPTKMT2AMEN1
SCHEMBL16953295 0.79 KDM4E (0.51) HPGDTSHRMAPTKMT2AMEN1
SCHEMBL4285039 0.79 KDM4E (0.48) HPGDTSHRMAPTKMT2AMEN1
SCHEMBL30977632 0.79 KMT2A (0.46) HPGDTSHRMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116507332-A Octahydroisoquinolinyl derivatives UCB生物制药有限责任公司 2023-07-28 CN disclosed
WO-2022117678-A1 OCTAHYDROISOQUINOLINYL DERIVATIVES UCB Biopharma SRL (BE) 2022-06-09 WO disclosed